OS Therapies Incorporated (OSTX) is a publicly traded Healthcare sector company. As of July 2, 2026, OSTX trades at $1.85 with a market cap of $84.62M and a P/E ratio of -1.86. OSTX moved +2.21% today. Year to date, OSTX is +35.07%; over the trailing twelve months it is -6.22%. Its 52-week range spans $1.12 to $7.00. Analyst consensus is buy with an average price target of $9.50. Rallies surfaces OSTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
OS Therapies Incorporated (OSTX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. OSTX moved +2.21% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $1.85 |
| Market Cap | $84.62M |
| P/E Ratio | -1.86 |
| EPS | $-0.98 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.00 |
| 52-Week Low | $1.12 |
| Volume | 231.34K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-28.75M |
| Gross Margin | 0.00% |
2 analysts cover OSTX: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $9.50.